Metabasis Escapes Biotech Zombiedom (MBRX)
Metabasis Therapeutics (NASDAQ:MBRX) announced after the close today that its MB07133 has been granted orphan medicinal product status for the treatment of hepatocellular carcinoma (primary liver cancer) by the European ...Read Full Story »

